Quanta Appoints Dr. Paul Komenda as New Chief Medical Officer

NEXT STORY
Zealand Pharma completes equity investment in strategic partner Beta Bionics
PREV STORY
Orion Corporation and Fifth Corner Inc join forces to research solutions for improving the quality of life of prostate cancer patients
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Calithera Announces Enrollment of First Patient in CB-839 in Combination with Checkpoint Modulator

SOUTH SAN FRANCISCO, Calif., Aug. 04, 2016 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA), ...

author_avatar
NASDAQ Market News

ABLYNX ANNOUNCES RESULTS FOR THE FIRST NINE MONTHS OF 2017 AND A YEAR-TO-DATE BUSINESS UPDATE

REGULATED INFORMATION Positive Phase III results with caplacizumab and a successful U.S. IPO GHENT, ...

author_avatar
NASDAQ Market News

Chembio Diagnostics to Report Fourth Quarter and 2017 Financial Results on March 8, 2018

MEDFORD, N.Y., Feb. 22, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader ...

author_avatar
NASDAQ Market News